Ishita Gajjar

Increased Moxifloxacin Dosing Among Patients With Multidrug-Resistant Tuberculosis With Low-Level Resistance to Moxifloxacin Did Not Improve Treatment Outcomes in a Tertiary Care Center in Mumbai, India

Amita Gupta, L. Pinto, Z. Udwadia, 2021, Open forum infectious diseases.

Cycloserine did not increase depression incidence or severity at standard dosing for multidrug-resistant tuberculosis

Amita Gupta, L. Pinto, Z. Udwadia, 2021, European Respiratory Journal.